Ascendis Pharma A/S 6-K Filing
Ticker: ASND · Form: 6-K · Filed: Nov 12, 2025 · CIK: 1612042
Sentiment: neutral
Filing Stats: 224 words · 1 min read · ~1 pages · Grade level 13.8 · Accepted 2025-11-12 16:05:08
Filing Documents
- d88973d6k.htm (6-K) — 9KB
- d88973dex991.htm (EX-99.1) — 129KB
- g88973logo.jpg (GRAPHIC) — 6KB
- g88973logo11.jpg (GRAPHIC) — 2KB
- 0001193125-25-277532.txt ( ) — 151KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Ascendis Pharma A/S Date: November 12, 2025 By: /s/ Michael Wolff Jensen Michael Wolff Jensen Executive Vice President, Chief Legal Officer